Page 32 - Delaware Medical Journal - January/February 2020
P. 32

 REVIEW ARTICLE
        was associated with both brainstem
      
There was a trend for female gender and trigeminal length of treated nerve         bothersome facial numbness (p=0.06). None of the patients had any additional late central-nervous-system toxicities.
On review, we saw an association between radiographic vascular compromise (defined as having a visible blood vessel crossing the trigeminal nerve on CISS images) and a decreased risk of pain relapse when using the fractionated technique. This is possibly due to the trigeminal nerve healing faster than the simultaneously ablated blood vessel between doses.
REFERENCES
CONCLUSIONS
CyberKnife SRS is a non-invasive and effective treatment of medically and surgically intractable trigeminal neuralgia        patients’ facial pain. The main late toxicity is facial numbness, which is preferable in the vast majority of patients to TN pain.
Our novel technique of fractionating the radiosurgery dose allows us to give a higher dose to the trigeminal nerve while minimizing the risk of facial numbness. Our published abstract establishes dosimetric parameters to minimize the risk of facial numbness when using three consecutive fractions. This method is most             high-resolution MRI.
CONTRIBUTING AUTHORS
■ Sohan Shah graduated from the Charter School of Wilmington and is currently a major in Neuroscience at Johns Hopkins University in Baltimore, MD.
■ Serguei Castaneda, MD is the Chief Resident in Radiation Oncology at the Helen F. Graham Cancer Center in Newark.
■ Matthew Dzeda graduated from Garnet Valley High School in Glen Mills, PA. He plans to graduate in April 2020 with a BS in Chemistry and a Spanish minor at the University of Pittsburgh.
■ Sunjay Shah, MD is a Radiation Oncologist at the Helen F. Graham Cancer Center at ChristianaCare. He completed a fellowship in Brain Radiosurgery at the Thomas Jefferson University Hospital in Philadelphia and was the Founding Director of the CyberKnife program.
    1. (2018, August 13). Why Trigeminal Neuralgia Is Considered The “Suicide Disease.” [online] Available at: https://arizonapain.com/trigeminal-neuralgia- suicide-disease/ [Accessed 12 April 2019].
2. Krafft RM. Trigeminal neuralgia. Am Fam Physician. 2008;77(9):1291–1296.
3. Obermann, M. (2010). Treatment Options in Trigeminal Neuralgia. Therapeutic Advances in Neurological Disorders, [online] 3(2), pp.107-115. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3002644/ [Accessed 31 May 2019].
4. Winfree, D. (2019). Atypical Trigeminal Neuralgia Symptoms. [online] Neurosurgeons of New Jersey. Available at: https://www. neurosurgeonsofnewjersey.com/atypical-trigeminal-neuralgia-symptom/ [Accessed 30 May 2019].
5. Cheshire WP. Defining the Role for Gabapentin in the Treatment of Trigeminal Neuralgia: a Retrospective Study. J Pain 2002; 3: 137–142.
6. Microvascular decompression MVD: Mayfield Brain & Spine. [online] Available at: https://mayfieldclinic.com/pe-mvd.htm [Accessed 30 May 2019].
7. Rughani, A., Dumont, T., Lin, C., Tranmer, B. and Horgan, M. (2011). Safety of Microvascular Decompression for Trigeminal Neuralgia in the Elderly. Journal of Neurosurgery, [online] 115(2), pp.202-209. Available at: https://www.ncbi.nlm.nih.gov/pubmed/21568658 [Accessed 30 May 2019].
8. (2016, June 14). Trigeminal Neuralgia Treatments. [online] Available at: https://www.hopkinsmedicine.org/neurology_neurosurgery/centers_clinics/ trigeminal_neuralgia/trigeminal_neuralgia_treatments.html [Accessed 30 May 2019].
9. Urmc.rochester.edu. (2019). Percutaneous Rhizotomy - Treatments - For Patients - UR Neurosurgery - University of Rochester Medical Center. [online] Available at: https://www.urmc.rochester.edu/neurosurgery/for-patients/treatments/percutaneous-rhizotomy.aspx [Accessed 30 May 2019].
10. Neurosurgery. (2019). History and Technical Overview | Neurosurgery. [online] Available at: https://med.virginia.edu/neurosurgery/services/gamma- knife/for-physicians/history-and-technical-overview/ [Accessed 30 May 2019].
11. Pollock, B., Phuong, L., Foote, R., Stafford, S. and Gorman, D. (2001). High-dose Trigeminal Neuralgia Radiosurgery Associated with Increased Risk of Trigeminal Nerve Dysfunction. Neurosurgery, [online] 49(1), pp.58-64. Available at: https://www.ncbi.nlm.nih.gov/pubmed/11440460 [Accessed 30 May 2019].
12. Adler Jr, JR., Bower, R., Gupta, G., Lim, M., Efron, A., Gibbs, I. C., ... & Soltys, S. G. (2009). Nonisocentric Radiosurgical Rhizotomy for Trigeminal Neuralgia. Neurosurgery, 64 (suppl_2), A84-A90.
13. Karam SD., Tai A., Snider JW., et al. Refractory Trigeminal Neuralgia Treatment Outcomes Following CyberKnife Radiosurgery. https://www.ncbi.nlm. nih.gov/pmc/articles/PMC4273323/ Radiat. Oncol. 2014;9:257–210.
14. Romanelli, P., Conti, A., Bianchi, L., Bergantin, A., Martinotti, A., & Beltramo, G. (2017). Image-guided Robotic Radiosurgery for Trigeminal Neuralgia. Neurosurgery, 83(5), 1023-1030.
 32
Del Med J | January/February 2020 | Vol. 92 | No. 1





































































   30   31   32   33   34